480 related articles for article (PubMed ID: 29302950)
1. Use of Impella 5.0 Prior to Transcatheter Aortic Valve Replacement in a Patient with Severe Aortic Stenosis and Cardiogenic Shock.
Johnson DW; ErwinIII JP
J Heart Valve Dis; 2017 Jul; 26(4):485-487. PubMed ID: 29302950
[TBL] [Abstract][Full Text] [Related]
2. Cardiogenic Shock Complicating Transcatheter Aortic Valve Replacement Due to Severe Para-Valvular Regurgitation.
Alraies MC; Soud M; Pacha HM; Waksman R; Ben-Dor I
Cardiovasc Revasc Med; 2018; 19(3 Pt B):393-395. PubMed ID: 29146552
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
Almalla M; Kersten A; Altiok E; Marx N; Schröder JW
Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621
[TBL] [Abstract][Full Text] [Related]
4. Bail-Out Use of Impella CP as a Bridge to TAVI in a Cardiogenic Shock Patient: The "Pump-Rewiring" Technique.
Burzotta F; Nerla R; Trani C
J Invasive Cardiol; 2016 Jan; 28(1):E1-5. PubMed ID: 26716594
[TBL] [Abstract][Full Text] [Related]
5. Emergent use of Impella CP™ during transcatheter aortic valve replacement: Transaortic access.
Singh V; Yarkoni A; O'Neill WW
Catheter Cardiovasc Interv; 2015 Jul; 86(1):160-3. PubMed ID: 25529629
[TBL] [Abstract][Full Text] [Related]
6. Application of Impella Mechanical Circulatory Support Devices in Transcatheter Aortic Valve Replacement and Balloon Aortic Valvuloplasty: A Single-Center Experience.
Almajed MR; Mahmood S; Obri M; Nona P; Gonzalez PE; Chiang M; Wang DD; Frisoli T; Lee J; Basir M; O'Neill B; O'Neill W; Villablanca P
Cardiovasc Revasc Med; 2023 Aug; 53():1-7. PubMed ID: 37012106
[TBL] [Abstract][Full Text] [Related]
7. Techniques to overcome difficult delivery of the Impella CP device through a previously placed transcatheter aortic valve.
Whitbeck MG; Chambers JW; Brilakis E
Cardiovasc Revasc Med; 2024 May; 62():123-129. PubMed ID: 38052716
[TBL] [Abstract][Full Text] [Related]
8. Emergency valve-in-valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno-arterial extracorporeal membrane oxygenation.
Summers MR; Mick S; Kapadia SR; Krishnaswamy A
Catheter Cardiovasc Interv; 2018 Sep; 92(3):592-596. PubMed ID: 28296034
[TBL] [Abstract][Full Text] [Related]
9. Emergent use of retrograde left ventricular support in patients after transcatheter aortic valve replacement.
Martinez CA; Singh V; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):E128-32. PubMed ID: 22888042
[TBL] [Abstract][Full Text] [Related]
10. Aortic Regurgitation after TAVR: From Bad to Worse.
Hiltrop N; Adriaenssens T; Herijgers P; Dubois C
J Heart Valve Dis; 2016 Mar; 25(2):182-184. PubMed ID: 27989062
[TBL] [Abstract][Full Text] [Related]
11. Insertion of an Abiomed Impella® left ventricular assist device following bioprosthetic aortic valve placement.
Thomas MP; Altman A; Magovern GJ; Moraca RJ
J Card Surg; 2013 Jul; 28(4):469-71. PubMed ID: 23675749
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
[TBL] [Abstract][Full Text] [Related]
13. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Aortic Valve Replacement: Comprehensive Review and Present Status.
Arora S; Misenheimer JA; Ramaraj R
Tex Heart Inst J; 2017 Feb; 44(1):29-38. PubMed ID: 28265210
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
[TBL] [Abstract][Full Text] [Related]
17. Staged High-Risk Percutaneous Coronary Intervention with Impella Support after On-Pump Transcatheter Aortic Valve Replacement.
Arora S; Bahekar AA
Tex Heart Inst J; 2016 Oct; 43(5):423-427. PubMed ID: 27777528
[TBL] [Abstract][Full Text] [Related]
18. Management of severe aortic regurgitation in a patient with cardiogenic shock using a percutaneous left ventricular assist device and transcatheter occlusion of the failed aortic valve homograft as a bridge to surgical valve replacement.
Pollak P; Lim DS; Kern J
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E141-5. PubMed ID: 23674479
[TBL] [Abstract][Full Text] [Related]
19. Axillary transvalvular microaxial pump as extended bridge to transcatheter aortic valve replacement in cardiogenic shock with severe aortic stenosis.
Abraham J; Wang L; Kumar V; Kirker EB; Spinelli KJ
J Heart Lung Transplant; 2022 Apr; 41(4):434-437. PubMed ID: 35090810
[TBL] [Abstract][Full Text] [Related]
20. Balloon Repositioning of Transcatheter Aortic Valve after Migration into the Left Ventricular Outflow Tract, Followed by Valve-in-Valve Procedure.
Ito M; Tada N; Hata M
Tex Heart Inst J; 2017 Aug; 44(4):274-278. PubMed ID: 28878583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
